Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings
HIV Infection
About this trial
This is an interventional supportive care trial for HIV Infection focused on measuring Adolescence, Adherence
Eligibility Criteria
Inclusion Criteria:
- youth aged 15-19 years receiving 1st-line ART for at least 3 months;
- exhibiting risk factors of detectable Viral Load and/or unprotected vaginal/anal intercourse in the previous 6 months;
- fluent in spoken Haitian Creole which is required to complete assessments and to participate in the intervention groups;
- willing to a) assent to study participation if under 18, and b) having a parent or caregiver aged >18 years provide informed consent and participate in the caregiver workshops.
Exclusion Criteria:
- cognitively impaired, as determined by the Test of Nonverbal Intelligence (TONI), since such impairment may compromise the ability to comprehend and participate in the assessment and intervention;
- exhibits bipolar disorder, psychosis, or current need for inpatient psychiatric hospitalization.
Sites / Locations
- GHESKIO Centers
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Placebo Comparator
N'ap Grandi
N'ap Grandi - A
Health Promotion - A
Both Adolescent and Caregiver participate in assessment and intervention groups. Adolescent assessments will be administered at baseline, 3 months- and 6 months-post intervention. Caregiver assessments will be administered at baseline and 6 months-post intervention.
Adolescents participate in assessment and intervention groups, Caregivers participate in assessment only. Adolescent assessments will be administered at baseline, 3 months- and 6 months-post intervention. Caregiver assessments will be administered at baseline and 6 months-post intervention.
Adolescents participate in assessment and intervention groups, Caregivers participate in assessment only. Adolescent assessments will be administered at baseline, 3 months- and 6 months-post intervention. Caregiver assessments will be administered at baseline and 6 months-post intervention.